{"pmid":32379080,"title":"Protecting Surgical Teams During the COVID-19 Outbreak: A Narrative Review and Clinical Considerations.","text":["Protecting Surgical Teams During the COVID-19 Outbreak: A Narrative Review and Clinical Considerations.","Ann Surg","Brat, Gabriel A","Hersey, Sean","Chhabra, Karan","Gupta, Alok","Scott, John","32379080"],"journal":"Ann Surg","authors":["Brat, Gabriel A","Hersey, Sean","Chhabra, Karan","Gupta, Alok","Scott, John"],"date":"2020-05-08T11:00:00Z","year":2020,"_id":"32379080","source":"PubMed","week":"202019|May 04 - May 10","doi":"10.1097/SLA.0000000000003926","topics":["Prevention"],"weight":1,"_version_":1666596532315488256,"score":9.490897,"similar":[{"pmid":32259130,"pmcid":"PMC7117787","title":"Epidemiological and Clinical Aspects of COVID-19; a Narrative Review.","text":["Epidemiological and Clinical Aspects of COVID-19; a Narrative Review.","There are significant misconceptions and many obstacles in the way of illuminating the epidemiological and clinical aspects of COVID-19 as a new emerging epidemic. In addition, usefulness of some evidence published in the context of the recent epidemic for decision making in clinic as well as public health is questionable. However, misinterpreting or ignoring strong evidence in clinical practice and public health probably results in less effective and somehow more harmful decisions for individuals as well as subgroups in general populations of countries in the initial stages of this epidemic. Accordingly, our narrative review appraised epidemiological and clinical aspects of the disease including genetic diversity of coronavirus genus, mode of transmission, incubation period, infectivity, pathogenicity, virulence, immunogenicity, diagnosis, surveillance, clinical case management and also successful measures for preventing its spread in some communities.","Arch Acad Emerg Med","Kolifarhood, Goodarz","Aghaali, Mohammad","Mozafar Saadati, Hossein","Taherpour, Niloufar","Rahimi, Sajjad","Izadi, Neda","Hashemi Nazari, Seyed Saeed","32259130"],"abstract":["There are significant misconceptions and many obstacles in the way of illuminating the epidemiological and clinical aspects of COVID-19 as a new emerging epidemic. In addition, usefulness of some evidence published in the context of the recent epidemic for decision making in clinic as well as public health is questionable. However, misinterpreting or ignoring strong evidence in clinical practice and public health probably results in less effective and somehow more harmful decisions for individuals as well as subgroups in general populations of countries in the initial stages of this epidemic. Accordingly, our narrative review appraised epidemiological and clinical aspects of the disease including genetic diversity of coronavirus genus, mode of transmission, incubation period, infectivity, pathogenicity, virulence, immunogenicity, diagnosis, surveillance, clinical case management and also successful measures for preventing its spread in some communities."],"journal":"Arch Acad Emerg Med","authors":["Kolifarhood, Goodarz","Aghaali, Mohammad","Mozafar Saadati, Hossein","Taherpour, Niloufar","Rahimi, Sajjad","Izadi, Neda","Hashemi Nazari, Seyed Saeed"],"date":"2020-04-08T11:00:00Z","year":2020,"_id":"32259130","source":"PubMed","week":"202015|Apr 06 - Apr 12","keywords":["covid-19","communicable diseases","emerging","epidemiology","public health","severe acute respiratory syndrome coronavirus 2"],"topics":["Prevention","Diagnosis"],"weight":1,"_version_":1666138493150035968,"score":46.885803},{"pmid":32246849,"title":"Personal protective equipment during the coronavirus disease (COVID) 2019 pandemic - a narrative review.","text":["Personal protective equipment during the coronavirus disease (COVID) 2019 pandemic - a narrative review.","Personal protective equipment has become an important and emotive subject during the current coronavirus disease 2019 epidemic. Coronavirus disease 2019 is predominantly caused by contact or droplet transmission attributed to relatively large respiratory particles which are subject to gravitational forces and travel only approximately 1 metre from the patient. Airborne transmission may occur if patient respiratory activity or medical procedures generate respiratory aerosols. These aerosols contain particles that may travel much longer distances and remain airborne longer, but their infective potential is uncertain. Contact, droplet and airborne transmission are each relevant during airway manoeuvres in infected patients, particularly during tracheal intubation. Personal protective equipment is an important component, but only one part, of a system protecting staff and other patients from coronavirus disease 2019 cross-infection. Appropriate use significantly reduces risk of viral transmission. Personal protective equipment should logically be matched to the potential mode of viral transmission occurring during patient care - contact, droplet or airborne. Recommendations from international organisations are broadly consistent, but equipment use is not. Only airborne precautions include a fitted high-filtration mask, and this should be reserved for aerosol generating procedures. Uncertainty remains around certain details of personal protective equipment including use of hoods, mask type and the potential for re-use of equipment.","Anaesthesia","Cook, T M","32246849"],"abstract":["Personal protective equipment has become an important and emotive subject during the current coronavirus disease 2019 epidemic. Coronavirus disease 2019 is predominantly caused by contact or droplet transmission attributed to relatively large respiratory particles which are subject to gravitational forces and travel only approximately 1 metre from the patient. Airborne transmission may occur if patient respiratory activity or medical procedures generate respiratory aerosols. These aerosols contain particles that may travel much longer distances and remain airborne longer, but their infective potential is uncertain. Contact, droplet and airborne transmission are each relevant during airway manoeuvres in infected patients, particularly during tracheal intubation. Personal protective equipment is an important component, but only one part, of a system protecting staff and other patients from coronavirus disease 2019 cross-infection. Appropriate use significantly reduces risk of viral transmission. Personal protective equipment should logically be matched to the potential mode of viral transmission occurring during patient care - contact, droplet or airborne. Recommendations from international organisations are broadly consistent, but equipment use is not. Only airborne precautions include a fitted high-filtration mask, and this should be reserved for aerosol generating procedures. Uncertainty remains around certain details of personal protective equipment including use of hoods, mask type and the potential for re-use of equipment."],"journal":"Anaesthesia","authors":["Cook, T M"],"date":"2020-04-05T11:00:00Z","year":2020,"_id":"32246849","source":"PubMed","week":"202014|Mar 30 - Apr 05","doi":"10.1111/anae.15071","keywords":["covid-19","airborne","contact","coronavirus","droplet","personal protective equipment"],"topics":["Prevention"],"weight":1,"_version_":1666138492063711233,"score":43.187485},{"pmid":32447168,"title":"COVID-19 patients for tracheostomy: Anesthetic and team considerations.","text":["COVID-19 patients for tracheostomy: Anesthetic and team considerations.","J Clin Anesth","Parekh, Raj M","Lai, Yan H","32447168"],"journal":"J Clin Anesth","authors":["Parekh, Raj M","Lai, Yan H"],"date":"2020-05-25T11:00:00Z","year":2020,"_id":"32447168","source":"PubMed","week":"202022|May 25 - May 31","doi":"10.1016/j.jclinane.2020.109883","locations":["Anesthetic"],"topics":["Prevention"],"weight":1,"_version_":1667698385951391744,"score":42.099884},{"pmid":32449614,"title":"Gender differences in patients with COVID-19: a narrative review.","text":["Gender differences in patients with COVID-19: a narrative review.","In December 2019 a novel coronavirus emerged in Wuhan, China causing many cases of severe pneumonia. World Health Organization (WHO) named this disease Coronavirus Disease 2019 (COVID-19). The infection has rapidly spread across China to many other countries, and on March 12, 2020 the WHO declared pandemic outbreak of COVID-19. As of May 16, 2020, COVID-19 has been diagnosed in more than 4,490,000 patients, associated to 305,976 deaths worldwide; in Italy 224,760 COVID-19 cases have been reported with 31,763 deaths. The main routes of transmission are respiratory droplets and direct contact with infected people, so numerous prevention strategies are employed to mitigate the spread of disease, including social distancing and isolation. The aim of this narrative review is to underline gender differences in epidemiology, etiopathogenesis, risk factors, clinical presentation, diagnosis, prognosis and mortality of patients infected with SARS-CoV-2. Currently data on the sex indicators for admitted or deceased patients are only available, but there is no analysis about other gender indicators. The data considered in our study are the only currently available in the literature, but it is appropriate to implement a specific analysis with all gender indicators to identify appropriate strategies. Moreover, the evaluation of a health service efficiency is a key element to define gender outcomes. Knowing the gender differences in COVID-19 outbreak would be a fundamental tool to understand the effects of a health emergency on individuals and communities as well as to carry out effective and equitable policies, public health measures and targeted solutions.","Monaldi Arch Chest Dis","Ambrosino, Immacolata","Barbagelata, Elena","Ortona, Elena","Ruggieri, Anna","Massiah, Grace","Giannico, Orazio Valerio","Politi, Cecilia","Moretti, Anna Maria","32449614"],"abstract":["In December 2019 a novel coronavirus emerged in Wuhan, China causing many cases of severe pneumonia. World Health Organization (WHO) named this disease Coronavirus Disease 2019 (COVID-19). The infection has rapidly spread across China to many other countries, and on March 12, 2020 the WHO declared pandemic outbreak of COVID-19. As of May 16, 2020, COVID-19 has been diagnosed in more than 4,490,000 patients, associated to 305,976 deaths worldwide; in Italy 224,760 COVID-19 cases have been reported with 31,763 deaths. The main routes of transmission are respiratory droplets and direct contact with infected people, so numerous prevention strategies are employed to mitigate the spread of disease, including social distancing and isolation. The aim of this narrative review is to underline gender differences in epidemiology, etiopathogenesis, risk factors, clinical presentation, diagnosis, prognosis and mortality of patients infected with SARS-CoV-2. Currently data on the sex indicators for admitted or deceased patients are only available, but there is no analysis about other gender indicators. The data considered in our study are the only currently available in the literature, but it is appropriate to implement a specific analysis with all gender indicators to identify appropriate strategies. Moreover, the evaluation of a health service efficiency is a key element to define gender outcomes. Knowing the gender differences in COVID-19 outbreak would be a fundamental tool to understand the effects of a health emergency on individuals and communities as well as to carry out effective and equitable policies, public health measures and targeted solutions."],"journal":"Monaldi Arch Chest Dis","authors":["Ambrosino, Immacolata","Barbagelata, Elena","Ortona, Elena","Ruggieri, Anna","Massiah, Grace","Giannico, Orazio Valerio","Politi, Cecilia","Moretti, Anna Maria"],"date":"2020-05-26T11:00:00Z","year":2020,"_id":"32449614","source":"PubMed","week":"202022|May 25 - May 31","doi":"10.4081/monaldi.2020.1389","locations":["Wuhan","China","China","Italy"],"countries":["China","Italy"],"countries_codes":["CHN|China","ITA|Italy"],"topics":["Prevention"],"weight":1,"_version_":1667785213904683009,"score":40.274185}]}